Loading clinical trials...
Loading clinical trials...
OBJECTIVES: I. Determine the effect of SYNSORB Pk therapy on mortality and frequency of severe extrarenal complications observed in children with acute stage E. coli-associated hemolytic uremic syndro...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborators
NCT07308574 · aHUS, Atypical Hemolytic Uremic Syndrome
NCT06312644 · Ultomiris-exposed Pregnant/ Postpartum, Pregnancy, and more
NCT05996731 · Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and more
NCT05805202 · Atypical Hemolytic Uremic Syndrome
NCT05726916 · Hypertensive Emergency-associated Hemolytic Uremic Syndrome
Children's Hospital of Denver
Denver, Colorado
Alfred I. Dupont Institute
Wilmington, Delaware
Emory University School of Medicine
Atlanta, Georgia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions